lobbying_activities: 993886
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 993886 | 606afef9-7e70-412a-aea8-361d68a47b84 | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2010 | third_quarter | PHA | Controlled Drug Substances Act (21 USC 13) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-10-14T18:45:57.673000-04:00 |